WHO Strategy for prevention and control of Chronic
Respiratory Diseases
7. Priorities for WHO
Priorities for WHO include:
Development and evaluation of reproducible and inexpensive methodologies
to monitor COPD suitable for use in developing countries;
Identifying and addressing barriers to drug and essential device
accessibility, developing approaches to improve accessibility to essential drugs in low
income countries, designing and implementing a study of CRD drug and device availability
and pricing in low and middle income countries;
Identifying gaps in existing guidelines, using methodologies for
guideline development that are evidence-based and take into account public health
considerations like cost-effectiveness and feasibility specially in developing countries,
using the newly developed guidelines as the rational basis for inclusion of drugs into the
Essential Drugs List;
Strengthening research on primary and secondary prevention interventions
of CRD;
Identifying research priorities, which should include in addition to
prevention strategies, therapeutic regimens, alternative drug delivery systems,
traditional medicine and alternative therapeutic approaches;
Establishment and promotion of partnerships with professional,
scientific, and educational institutions to promote and implement the initiative.
Section 1 - Section 2 - Section 3 - Section 4 - Section 5 - Section 6- Section 7 |
